stars 1 stars 2 stars 3

Nucleai is the tissue intelligence layer for drug development and translational research. We pair AI-driven multimodal image analysis across H&E, IHC, mIF, and spatial transcriptomics with clinical outcomes linkage, delivered through our AI-driven computational platform and expert-led analysis. The result: structured tissue intelligence built to answer the two questions that determine a therapy's path: why does it work, and which patients will benefit. We work with two groups: biopharma sponsors across oncology, immunology, and metabolic disease turning tissue into program decisions, and the spatial biology platforms and research centers generating spatial biology data.

Nucleai Questions

The Nucleai annual revenue was $8 million in 2026.

Avi Veidman is the CEO of Nucleai.

42 people are employed at Nucleai.

Nucleai is based in Chicago, Illinois.

The NAICS codes for Nucleai are [51, 621, 6215, 62151, 62, 513].

The SIC codes for Nucleai are [807, 80].

Top Nucleai Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users